Skip to main navigation
Skip to content
Aerpio Pharmaceuticals
  • Home
  • Company
    • The Company
    • Leadership
    • Clinical Advisors
    • Board
    • Careers
  • Our Science
    • The mTOR Pathway
    • Publications and Abstracts
    • The Technology Platform
  • Our Medicine
    • Our Medicine
    • Advanced Malignant PEComa
  • Pipeline
    • Pipeline Clinical Studies
    • TSC1 and TSC2 Inactivating Alterations
  • Expanded Access
  • Investors & News
  • Contact Us
    • General Contact
    • For Healthcare Professionals
Aerpio Pharmaceuticals

Breadcrumb

  • Home >>
  • Investors >>
  • financial reports >>

Financial Reports

Financial Reports

Annual Reports
2021 Annual Report

Shareholder Tools

  • Print Page
  • RSS Feeds
  • Email Alerts
  • IR Contacts

Investor Relations

  • Investor Overview
  • Stock Information
    • Stock Quote & Chart
    • Analyst Coverage
  • Press Releases
  • Event Calendar
  • Corporate Presentations
  • Scientific Presentations
  • Financial Information
    • SEC Filings
    • Financial Reports
    • Quarterly Results
    • Forms
  • Corporate Governance
    • Governance Highlights
    • Committee Composition
  • Investor Resources
    • Investor FAQ
    • Information Request
    • E-mail Alerts
    • IR Contacts
  • Home
  • Leadership
  • Pipeline
  • Contact
  • Careers
  • Terms & Conditions
  • Privacy